About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Portland | 279 Studies

Clinical Trials Prostate CancerPortland

Prostate Cancer Clinical Trials in Portland

Find 279 clinical trials for prostate cancer near Portland, Oregon. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 279 trials

CompletedTadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation TherapyRATIONALE: Tadalafil may help prevent erectile dysfunction (ED) in patients with prostate cancer that has been treated with radiation therapy.NCT00931528·Birmingham, Alabama and 191 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedThe Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerThe purpose of this study is to evaluate the safety and optimal dose of RAD001 and docetaxel plus prednisone in men with hormone refractory, metastatic prostate cancer (Phase I).NCT00459186·Boston, Massachusetts and 4 others

Active not recruitingRadiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE TrialThis phase II trial studies how well radiation therapy with or without apalutamide works in treating patients with prostate cancer that has come back (recurrent).NCT03371719·Gilbert, Arizona and 359 others

CompletedS0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00028769·Mobile, Alabama and 90 others

CompletedProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyProvenge is an investigational product designed to activate a man's own antigen presenting cells, a type of immune cell, so that they can detect prostate cancer cells and initiate…NCT00065442·Laguna Hills, California and 70 others

RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 150 others

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

CompletedBicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerThe purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in…NCT00657904·Birmingham, Alabama and 84 others

CompletedA Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerThe purpose of this study is to look at the effects (good and bad) of the combination of docetaxel and carboplatin for patients who have progressive prostate cancer after…NCT00134706·Boston, Massachusetts and 5 others

RecruitingA Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerResearchers conducting this study hope to learn about the safety and effectiveness of combining two study drugs, relacorilant and enzalutamide, plus androgen deprivation therapy…NCT05726292·Chicago, Illinois and 3 others

Approved for marketingExpanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerThis study provides expanded access to radiotracer Gallium 68 (68Ga)-prostate-specific membrane antigen (PSMA)-HBED-CC (68Ga-PSMA-11) with Positron Emission Tomography (PET)…NCT04452136·Portland, Oregon

CompletedRadiologically Guided Biopsies of mCRPCThe purpose of this study is to better understand how cancer treatment may affect cancer cells.NCT02432001·Davis, California and 4 others

CompletedGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerThis randomized phase III trial studies gemcitabine hydrochloride, cisplatin, and bevacizumab to see how well they work compared with gemcitabine hydrochloride and cisplatin in…NCT00942331·Birmingham, Alabama and 872 others

CompletedZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementThis randomized phase III trial studies two different schedules of zoledronic acid to compare how well they work in reducing bone-related complications in patients with breast…NCT00869206·Fairbanks, Alaska and 503 others

CompletedIncreasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation TherapyThis trial studies how well increasing the dose of survivorship care planning improves care and outcomes in prostate cancer survivors receiving radiation therapy and androgen…NCT03860961·Kingman, Arizona and 78 others

RecruitingNeoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate CancerPembrolizumab will be administered at a dose of 200 mg will be administered as a 30 minute IV infusion every 3 weeks.NCT03753243·Portland, Oregon

RecruitingThe Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following…NCT06520345·Orange, California and 32 others

Active not recruitingPembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate CancerEligible patients will be treated with the combination of lenvatinib and pembrolizumab.NCT04848337·Duarte, California and 4 others

CompletedPlatform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel CombinationsThis study is designed to evaluate multiple clinical hypotheses and mechanistically-defined combinations to evaluate the safety and efficacy of immunotherapy combinations in…NCT03835533·Los Angeles, California and 5 others

CompletedCalcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00017576·Portland, Oregon

Page 1 of 14Next

Other Conditions in Portland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma